Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

786 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.
Berger T, Brochet B, Brambilla L, Giacomini PS, Montalbán X, Vasco Salgado A, Su R, Bretagne A. Berger T, et al. Among authors: montalban x. Mult Scler J Exp Transl Clin. 2019 Dec 2;5(4):2055217319887191. doi: 10.1177/2055217319887191. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31832225 Free PMC article.
One year follow up study of primary and transitional progressive multiple sclerosis.
Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Hintzen R, Montalban X, Polman CH, Rovira A, de Sa J, Thompson AJ. Stevenson VL, et al. Among authors: montalban x. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):713-8. doi: 10.1136/jnnp.68.6.713. J Neurol Neurosurg Psychiatry. 2000. PMID: 10811693 Free PMC article.
Two-year follow-up study of primary and transitional progressive multiple sclerosis.
Ingle GT, Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Thompson AJ. Ingle GT, et al. Among authors: montalban x. Mult Scler. 2002 Apr;8(2):108-14. doi: 10.1191/1352458502ms778oa. Mult Scler. 2002. PMID: 11990866
A longitudinal study of cognition in primary progressive multiple sclerosis.
Camp SJ, Stevenson VL, Thompson AJ, Ingle GT, Miller DH, Borras C, Brochet B, Dousset V, Falautano M, Filippi M, Kalkers NF, Montalban X, Polman CH, Langdon DW. Camp SJ, et al. Among authors: montalban x. Brain. 2005 Dec;128(Pt 12):2891-8. doi: 10.1093/brain/awh602. Epub 2005 Jul 27. Brain. 2005. PMID: 16049040
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ. Montalban X, et al. Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7. Mult Scler. 2009. PMID: 19995843
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Radue EW, et al. J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16. J Neurol Sci. 2010. PMID: 20236661 Clinical Trial.
786 results